期刊文献+

GRP78在食管癌细胞ECA-109增殖过程中的功能研究 被引量:2

Study the Function of GRP78 in Cell Proliferation Process in Esophageal Cancer Cell Line ECA-109
原文传递
导出
摘要 食管癌在中国是高发性肿瘤,并具有较高的致死率。肿瘤细胞的持续增殖与细胞增殖失调密切相关。肿瘤细胞在增殖过程中需要合成大量蛋白质,葡萄糖调节蛋白78(glucose regulatedprotein,GRP78)作为分子伴侣,在蛋白质的折叠、组装、修饰和错误折叠蛋白的降解过程中发挥着重要作用。该研究通过构建pGRP78-EGFP-N1重组质粒,瞬时转染ECA-109细胞,研究GRP78过表达对细胞增殖能力的影响;采用RNA干扰技术,瞬时转染靶向GRP78的siRNA,研究敲低GRP78对细胞增殖能力的影响。该研究发现GRP78过表达后,更多的细胞从G1期进入S期和G2/M期,细胞增殖速率加快,细胞克隆形成率亦明显提高;敲低GRP78后,细胞更多地被阻滞在G1期而无法进入S期和G2/M期,细胞增殖速率减慢,细胞克隆形成率降低。GRP78可能通过调节细胞周期而促进ECA-109细胞的增殖。 In China, esophageal cancer is a malignant tumor of high incidence and high mortality. Sus- tained proliferation of tumor cells is closely related to the cell proliferation disorder. Large amounts of proteins need to be synthesized during tumor cell proliferation process. GRP78 as a molecular chaperone, plays an important role in the process of protein folding, assembly, modification and misfolded protein degradation. The research studied the influence of proliferation ability with over-expression or knock-down of GRP78 in ECA-109 cells through tran- sient transfection of GRP78 recombinant plasmid pGRP78-EGFP-N1 or siRNA, respectively. The study found that after GRP78 over-expression, more cells converted from GI phage to S and GE/M phages, then cell proliferation rate and cell clony formation rate were increased; as well as after knock-down GRP78, more cells were arrested in G~ phage and couldn't transfer into S and GE/M phages, then cell proliferation rate and cell clony formation rate werereduced. GRP78 may promote ECA-109 cell proliferation by regulating the cell cycle.
出处 《中国细胞生物学学报》 CAS CSCD 北大核心 2013年第1期41-46,共6页 Chinese Journal of Cell Biology
基金 广东省教育厅高等学校高层次人才项目(批准号:粤教师函[2010]79号) 中国博士后科学基金(批准号:2012M511882)资助的课题~~
关键词 GRP78 过表达 RNA干扰 增殖 细胞周期 ECA-109细胞 GRP78 over-expression RNAi proliferation cell cycle ECA-109 cell
  • 相关文献

参考文献10

  • 1Pisani P, Parkin DM, Bray F, Ferlay J. Erratum: Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer, 83, 18-29 (1999). Int J Cancer 1999; 83(6): 870-3.
  • 2Oka M, Yamamoto K, Takahashi M, Hakozaki M, Abe T, Iizuka N, et al. Relationship between serum levels of interleukin 6, various disease parameters and malnutrition in patients with esophageal squamous cell carcinoma. Cancer Res 1996; 56(12): 2776-80.
  • 3陈万青,张思维,郑荣寿,雷正龙,李光琳,邹小农,赵平.中国肿瘤登记地区2007年肿瘤发病和死亡分析[J].中国肿瘤,2011,20(3):162-169. 被引量:329
  • 4Mayer MP, Bukau B. Hsp70 chaperones: Cellular functions and molecular mechanism. Cell Mol Life Sci 2005; 62(6): 670-84.
  • 5Dudek J, Benedix J, Cappel S, Greiner M, Jalal C, Muller L, et al. Functions and pathologies of BiP and its interaction partners. Cell Mol Life Sci 2009; 66(9): 1556-69.
  • 6Du XL, Hu H, Lin DC, Xia SH, Shen XM, Zhang Y, et al. Pro- teomic profiling of proteins dysregulted in Chinese esophageal squamous cell carcinoma. J Mol Med 2007; 85(8): 863-75.
  • 7Enzinger PC, Mayer RJ. Medical progress esophageal cancer. New Engl J Med 2003; 349: 2241-52.
  • 8Hanahan D, Weinberg RA. Hallmarks of cancer: the next genera- tion. Cell 2011; 144(5): 646-74.
  • 9Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature 2001; 411(6835): 342-8.
  • 10Sou SN, Ilieva KM, Polizzi KM. Binding of human BiP to the ER stress transducers IRE1 and PERK requires ATP. Biochem Biophys Res Commun 2012; 420(2): 473-8.

二级参考文献10

  • 1Bray F, Parkin DM, Evaluation of data quality in the cancer registry: Principles and methods. Part I : Comparability, validity and timeliness [J]. Eur J Cancer, 2009, 45(5): 747-755.
  • 2Curado MP, Edwards B, Shin HR et al. Cancer incidence in five conti- nents, Vol. IX. IARC scientific publications No. 160[M]. Lyon: IARC, 2007.
  • 3Parkin DM, Chen VW, Ferlay J, et al. Comparability and quality control in cancer registration. IAtlC technical report No.19[M]. Lyon: IARC. 1994.
  • 4Felay J, Burkhard C, Whelan S, et al. Check and conversion programs for cancer registries. IARC technical report No.42[M]. Lyon: IARC, 2005.
  • 5Felay J. The IARCcrgTools program [CP/OL]. http://www.iaer.com.fr/iarc- crgtools.htm, 2006.
  • 6全国肿瘤登记中心.中国肿瘤登记工作指导手册[M].北京:中国协和医科大学出版社,2004.48-50.
  • 7陈万青,张思维.中国肿瘤登记的代表性研究[J].中国肿瘤,2008,17(10):832-835. 被引量:12
  • 8陈万青,赵平,饶克勤,孔灵芝,胡建平.健全我国肿瘤登记系统[J].中华预防医学杂志,2010,44(5):374-375. 被引量:12
  • 9张思维,雷正龙,李光琳,邹小农,赵平,陈万青.中国肿瘤登记地区2006年肿瘤发病和死亡资料分析[J].中国肿瘤,2010,19(6):356-365. 被引量:193
  • 10陈建国.癌症登记资料的质量评价[J].中国肿瘤,1999,8(3):100-104. 被引量:38

共引文献328

同被引文献45

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部